Tag: Obesity
Novo Nordisk cuts forecasts after replica obesity drugs hit US take-up
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this…
America’s Fattest Cities Revealed In Shocking Obesity Rate Update
America's Fattest and Skinniest Cities Revealed: Shocking Obesity Rates According to recent studies, the top 10 fattest cities…
NIH internships, osteoarthritis, obesity tracker
Here is a look at some of the top health and medicine stories making headlines today: CANCELLED INTERNSHIP…
Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price
Novo Nordisk has announced that it will be offering its obesity drug Wegovy directly to patients at a…
Jay Bhattacharya, Medicaid cuts, obesity in 2050
The rise of infectious diseases in pets is becoming a growing concern, mirroring the increase in human diseases.…
Biocon Launches Diabetes, Obesity Management Drug In UK
New Delhi: Leading biotechnology company Biocon has recently introduced a groundbreaking product in the UK for managing diabetes…
Market pressure seen as fueling too much weight loss in new obesity drugs
Eli Lilly's next-generation obesity drug, known as retatrutide, is causing unexpected outcomes in ongoing trials. Instead of struggling…
Super Bowl Ad Raises Questions About Compounded V. Brand Obesity Meds
The ongoing debate surrounding the use of compounded weight loss drugs as a more affordable alternative to branded…
BMI Sidelined in New Obesity Definition That Favors Health Evaluation
A group of 58 researchers have challenged the traditional definition and diagnosis of obesity, arguing that current methods…
A new definition of obesity could help treat millions of people
Measuring body fat more carefully could help treat obesityHalfpoint/Getty Images Rethinking the way we define obesity could have…
Experts propose ‘preclinical’ and ‘clinical’ obesity
Shifting the focus away from BMI as the sole indicator of obesity opens up a new realm of…
Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver
The introduction of the anti-obesity drug Zepbound by Eli Lilly & Co. is projected to have a significant…